An Approval & a Rejection. Both Considered Good News. A Small Firm is Added to the Prohost Portfolio

The Week in Review #22
What Went Right or Wrong in the Biotech Sector During the Departing Week? - A lot happened in the biotech sector during the week, which departed at midnight. Topping the list of the week’s events was the approval of Portola’s (PTLA) product  Andexxa . . .

This content is for paid subscribers.
Please click here to subscribe or log in.